Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-24-000030

CEO sold 3,000 shares at an average $15.04 ($45,129)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Doshi Dipal CEO 2024-05-16 Sale 10b5-1 −1,800 $15.00 $27,000 338,575 D
Doshi Dipal CEO 2024-05-17 Sale 10b5-1 −1,200 $15.11 $18,129 337,375 D
Open-market sales · 3,000 sh · avg $15.04 · $45,129
Loading xslF345X05/wk-form4_1716240109.xml…